Matthew Kane
Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsAbout Matthew Kane
Matthew Kane is recorded as CEO at Precision Biosciences Inc (DTIL). The proxy statement of Precision Biosciences Inc reports total compensation of $1,836,601 for Matthew Kane in fiscal 2020, including a base salary of $523,000. Disclosed compensation is on record for 3 fiscal years. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Naresh Tanna (CFO), Alex Kelly (COO and Chief Accounting Officer), Dario Scimeca (General Counsel) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Precision Biosciences Inc
- Naresh Tanna CFO
- Alex Kelly COO, Chief Accounting Officer
- Dario Scimeca General Counsel
- Mei Burris Chief Accounting Officer
- Shane Barton Chief Accounting Officer
- Geno Germano Board Member
- Melinda Brown Board Member
- Michael Amoroso Board Member
- Samuel Wadsworth Board Member
- Samuel Wadsworth, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Precision Biosciences Inc (DTIL) | President and Chief Executive Officer | $523,000 | $1,836,601 |
| 2019 | Precision Biosciences Inc (DTIL) | President and Chief Executive Officer | $479,750 | $2,166,460 |
| 2018 | Precision Biosciences Inc (DTIL) | President and Chief Executive Officer | $350,000 | $1,587,132 |
Recent activity
No call appearances or filed executive changes recorded yet.